Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials”.
A Fernandez-Martinez, Françoise Rothé, EP Winer, David Venet, I.E. Krop +17 more
Jonathan C. Silverstein, AURORA US Network, Melina E Sanders, P.W. Laird, C.M. Perou +53 more